Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 14 records, 2 pages
Search For: Insulin Lispro
Global Insulin Lispro Supply, Demand and Key Producers, 2024-2030
21 Feb 2024
Pharma & Healthcare
The global Insulin Lispro market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Insulin Lispro Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Insulin Lispro market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Biosimilar Insulin Lispro Supply, Demand and Key Producers, 2024-2030
18 Feb 2024
Pharma & Healthcare
The global Biosimilar Insulin Lispro market size is expected to reach $ 633.5 million by 2030, rising at a market growth of 2.7% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Biosimilar Insulin Lispro Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
09 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Biosimilar Insulin Lispro market size was valued at USD 526.4 million in 2023 and is forecast to a readjusted size of USD 633.5 million by 2030 with a CAGR of 2.7% during review period.
USD3480.00
Add To Cart
Global Recombinant Insulin Lispro Injection Supply, Demand and Key Producers, 2024-2030
11 Feb 2024
Medical Devices & Consumables
Recombinant Insulin Lispro Injection
The global Recombinant Insulin Lispro Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Recombinant Insulin Lispro Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
07 Jan 2024
Medical Devices & Consumables
Recombinant Insulin Lispro Injection
According to our (Global Info Research) latest study, the global Recombinant Insulin Lispro Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Mixed Protamine Zinc Recombinant Human Insulin Lispro Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
22 Jan 2024
Pharma & Healthcare
Mixed Protamine Zinc Recombinant Human Insulin Lispro Injection
According to our (Global Info Research) latest study, the global Mixed Protamine Zinc Recombinant Human Insulin Lispro Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Insulin Lispro Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
18 Mar 2023
Pharma & Healthcare
Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals to prevent postprandial hyperglycemia. Its absorption is more rapid than regular insulin. It is made by reversing the amino acids lysine and proline in the beta chain of the insulin polypeptide.
USD3480.00
Add To Cart
Global Biosimilar Insulin Lispro Supply, Demand and Key Producers, 2023-2029
25 Feb 2023
Pharma & Healthcare
The global Biosimilar Insulin Lispro market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Biosimilar Insulin Lispro Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
09 Jan 2023
Pharma & Healthcare
Insulin lispro Sanofi is a 'biosimilar medicine'. This means that it is highly similar to a biological medicine (also known as the 'reference medicine') that is already authorised in the European Union (EU). The reference medicine for Insulin lispro Sanofi is Humalog 100 U/ml solution
USD3480.00
Add To Cart
- 1
- 2
Go To Page
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Insulin Lispro
Total: 14 records, 2 pages
The global Insulin Lispro market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Insulin Lispro market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
The global Biosimilar Insulin Lispro market size is expected to reach $ 633.5 million by 2030, rising at a market growth of 2.7% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Biosimilar Insulin Lispro market size was valued at USD 526.4 million in 2023 and is forecast to a readjusted size of USD 633.5 million by 2030 with a CAGR of 2.7% during review period.
USD3480.00
Add To Cart
The global Recombinant Insulin Lispro Injection market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Recombinant Insulin Lispro Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Mixed Protamine Zinc Recombinant Human Insulin Lispro Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals to prevent postprandial hyperglycemia. Its absorption is more rapid than regular insulin. It is made by reversing the amino acids lysine and proline in the beta chain of the insulin polypeptide.
USD3480.00
Add To Cart
The global Biosimilar Insulin Lispro market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Insulin lispro Sanofi is a 'biosimilar medicine'. This means that it is highly similar to a biological medicine (also known as the 'reference medicine') that is already authorised in the European Union (EU). The reference medicine for Insulin lispro Sanofi is Humalog 100 U/ml solution
USD3480.00
Add To Cart
- 1
- 2
Go To Page
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>